IMC Chicago
NVCR icon

IMC Chicago’s NovoCure NVCR Stock Holding History

IMC Chicago’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$194K Sell
12,833
-17,859
-58% -$270K ﹤0.01% 5698
2026
Q1 		$335K Sell
30,692
-11,217
-27% -$140K ﹤0.01% 4465
2025
Q4 		$542K Buy
41,909
+9,375
+29% +$120K ﹤0.01% 3419
2025
Q3 		$420K Buy
32,534
+12,764
+65% +$171K ﹤0.01% 3273
2025
Q2 		$352K Buy
+19,770
New +$345K ﹤0.01% 3038

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

IMC Chicago's NVCR Position: Q2 2026 in Review

IMC Chicago reduced its NovoCure (NVCR) stake by 58% in Q2 2026, selling an estimated $270K and leaving 12,833 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #5698.

IMC Chicago first reported a position in NVCR in Q2 2025 and has held it in 5 quarters since. The position peaked at $542K in Q4 2025. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • IMC Chicago held 12,833 shares of NovoCure worth $194K as of Q2 2026.
  • IMC Chicago sold 17,859 NovoCure shares in Q2 2026, an estimated $270K.
  • NovoCure made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #5698 holding.
  • IMC Chicago first reported a position in NovoCure in Q2 2025 and has held it in 5 quarters since.
  • IMC Chicago's NovoCure position peaked at $542K in Q4 2025.
  • 216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.